Obeyesekere, Manoj N <br/><br/>
Left ventricular ejection fraction and absence of ACE inhibitor/angiotensin II receptor blocker predicts appropriate defibrillator therapy in the primary prevention population.  [electronic resource] 

 -  Pacing and clinical electrophysiology : PACE  Jun 2010 
 - 696-704 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1540-8159 
<br/><br/><label>Standard No.: </label>10.1111/j.1540-8159.2009.02669.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Angiotensin II Type 1 Receptor Blockers--therapeutic use<br/>Angiotensin-Converting Enzyme Inhibitors--therapeutic use<br/>Cardiomyopathies--drug therapy<br/>Death, Sudden, Cardiac--prevention & control<br/>Defibrillators, Implantable<br/>Female<br/>Follow-Up Studies<br/>Heart Failure--drug therapy<br/>Humans<br/>Male<br/>Middle Aged<br/>Receptors, Angiotensin--drug effects<br/>Stroke Volume--drug effects<br/>Tachycardia, Ventricular--therapy<br/>Treatment Outcome<br/>Ventricular Dysfunction, Left--drug therapy<br/>Ventricular Fibrillation--therapy<br/>Ventricular Function, Left--drug effects